Answers are grounded in this paper and cite their sources.
Aim This paper is not a guideline, but aims to discuss practical considerations in managing children with recurrent urinary tract infections (UTIs) in the context of bowel and bladder dysfunction (BBD). Methods This clinically focussed narrative review, supported by references, discusses and highlights important points for clinicians to consider when managing UTI in the context of BBD in children. Results To address the problem, clinicians should undertake holistic assessment of the authenticity, nature, frequency and severity of previous UTIs; as well as carefully assess for and characterise UTI risk factors, especially BBD. Dysbiosis of the urobiome and microbiome may be associated with bladder dysfunction and UTIs in children, an area under research. Optimal treatment of BBD reduces UTI risk, and practical aspects of BBD management are discussed. The role of continuous antibiotic prophylaxis (CAP) in reducing UTI risk is assessed; as well as the options of non‐antibiotic UTI risk reduction measures. Conclusion BBD management reduces UTI risk overall. CAP is reasonable to consider until BBD management is optimal. Non‐antibiotic prophylaxis may also contribute to UTI risk reduction.
No takes yet. Share an insight, caveat, or question.
Naeem Samnakay (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: